Evaluating the benefit of adaptive randomization in the CC-115 arm of the Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A phase II randomized Bayesian adaptive platform trial in newly diagnosed MGMT unmethylated glioblastoma.
暂无分享,去创建一个
P. Wen | K. Ligon | L. Trippa | D. Schiff | M. Ahluwalia | H. Colman | E. Lee | B. Alexander | D. Reardon | E. Galanis | L. Nabors | J. Hepel | R. Rahman | M. Touat | J. Drappatz | David M. Meredith | I. Arrillaga-Romany | G. Fell | M. Welch | E. Chiocca